Urinary system neoplasm
MONDO:0021066A benign or malignant, primary or metastatic neoplasm involving the urinary system. --2003
Also known as: neoplasm of renal system, neoplasm of the urinary system, neoplasm of the urinary tract, neoplasm of urinary system, neoplasm of urinary tract, renal system neoplasm, renal system neoplasm (disease), renal system tumor
2992 clinical trials for this condition and its sub-types, 21 tagged with Urinary system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary system neoplasm
-
Malignant urinary system neoplasm 75 trials · 1,664 incl. sub-types
10 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 2B 2 trials
- Malignant prostate phyllodes tumor 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Kidney neoplasm 59 trials · 860 incl. sub-types
8 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Childhood kidney neoplasm 1 trial · 30 incl. sub-types Sub-types →
- Renal pelvis neoplasm 1 trial · 24 incl. sub-types Sub-types →
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Mesonephric neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Kidney hemangiopericytoma 0 trials
- Mixed epithelial stromal tumor of the kidney 0 trials Sub-types →
- Multiloculated renal cyst 0 trials
-
Urinary bladder neoplasm 65 trials · 699 incl. sub-types
6 sub-types
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Bladder flat intraepithelial lesion 0 trials · 30 incl. sub-types Sub-types →
- Bladder papillary urothelial neoplasm 1 trial · 13 incl. sub-types Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Bladder inflammatory myofibroblastic tumor 0 trials
- Urinary bladder villous adenoma 0 trials
-
Urothelial neoplasm 2 trials · 693 incl. sub-types
5 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Papillary urothelial neoplasm 0 trials · 13 incl. sub-types Sub-types →
- Urinary tract non-invasive transitional cell neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Urothelial dysplasia 0 trials
-
Benign urinary system neoplasm 50 trials · 62 incl. sub-types
6 sub-types
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Benign prostate phyllodes tumor 0 trials
- Benign urethral neoplasm 0 trials Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Urothelial papilloma 0 trials Sub-types →
-
Ureter neoplasm 2 trials · 34 incl. sub-types
3 sub-types
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Polyp of ureter 0 trials
-
Urethra neoplasm 3 trials · 31 incl. sub-types
3 sub-types
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Benign urethral neoplasm 0 trials Sub-types →
- Urethral villous adenoma 0 trials
-
Prostate phyllodes tumor 0 trials
2 sub-types
- Benign prostate phyllodes tumor 0 trials
- Malignant prostate phyllodes tumor 0 trials
Most studied deeper sub-types
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a two-drug combination (tucatinib and trastuzumab) in people with advanced solid tumors that have HER2 alterations. The goal is to see if the treatment can shrink or control tumors. About 217 participants with various cancers (like lung, uterine, or bile duct) wi…
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New immunotherapy combo may save bladders in cancer patients
Disease control OngoingThis phase 2 trial tests two immunotherapy drugs, nivolumab and relatlimab, given before surgery for stage II-IIIa bladder cancer. The goal is to see if the combination can eliminate the tumor, allowing patients to keep their bladder instead of having it removed. About 90 partici…
Phase 2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for rare kidney cancer: targeted drug savolitinib faces off against standard therapy
Disease control OngoingThis phase 3 study compares a new drug, savolitinib, to the standard drug sunitinib in 60 people with a specific type of advanced kidney cancer called MET-driven papillary renal cell carcinoma. The goal is to see if savolitinib is better at stopping the cancer from growing and to…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a testosterone shot before surgery speed recovery?
Disease control OngoingThis early-phase trial is testing whether giving testosterone replacement therapy to men with low testosterone before and after major urologic surgery is safe and might improve recovery. Researchers will track quality of life, frailty, complications, hospital stay length, and rea…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New targeted drug aims to fight hard-to-treat bladder cancers
Disease control OngoingThis study tests a new drug called TYRA300 in people with advanced bladder cancer or other solid tumors that have a specific change in the FGFR3 gene. The goal is to find the best dose and see if the drug can shrink tumors. About 310 adults whose cancer has not responded to stand…
Phase 1/2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC